An observational study in Colon Adenoma, sponsored by Konkuk University Medical Center. Status unknown at 1 site in Korea, Republic of. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-11-14.
Sponsored by Konkuk University Medical Center · Observational
The fecal calprotectin assay is used widely for inflammatory bowel disease diagnosis and the assessment of the disease activity. Some adenoma patients have elevated fecal calprotectin level, which could mean the role of fecal calprotectin as a screening marker for colon adenoma. We will investigate the usefulness of fecal calprotectin as colon adenoma marker for screening in this study.
657 studies on the registry are indexed under Adenoma; 98 are open to participants now.
This study's planned enrollment of 500 is above the median of 300 across 226 observational studies indexed under Adenoma.
Browse Adenoma studies →Konkuk University Medical Center is the lead sponsor of 93 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients who visit KUH healthcare center for colonoscopy in Korea over 18 years old adult population
Exclusion Criteria:
fecal calprotectin level
Time frame: 1 day (at the hospital visit)
This study is status unknown, as verified in Nov 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Konkuk University Medical Center